{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:36:54Z","timestamp":1791196614184,"version":"4.1.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epstein-Barr virus (EBV) is associated with a variety of lymphoid malignancies. Bortezomib activates EBV lytic gene expression. Bortezomib, a proteasome inhibitor, leads to increased levels of CCAAT\/enhancer-binding protein\u03b2 (C\/EBP\u03b2) in a variety of tumor cell lines. C\/EBP\u03b2 activates the promoter of the EBV lytic switch gene ZTA. Bortezomib treatment leads to increased binding of C\/EBP to previously recognized binding sites in the ZTA promoter. Knockdown of C\/EBP\u03b2 inhibits bortezomib activation of EBV lytic gene expression. Bortezomib also induces the unfolded protein response (UPR), as evidenced by increases in ATF4, CHOP10, and XBP1s and cleavage of ATF6. Thapsigargin, an inducer of the UPR that does not interfere with proteasome function, also induces EBV lytic gene expression. The effects of thapsigargin on EBV lytic gene expression are also inhibited by C\/EBP\u03b2 knock-down. Therefore, C\/EBP\u03b2 mediates the activation of EBV lytic gene expression associated with bortezomib and another UPR inducer.<\/jats:p>","DOI":"10.1182\/blood-2011-01-332379","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T04:41:12Z","timestamp":1301460072000},"page":"6297-6303","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":77,"title":["Bortezomib induction of C\/EBP\u03b2 mediates Epstein-Barr virus lytic activation in Burkitt lymphoma"],"prefix":"10.1182","volume":"117","author":[{"given":"Courtney M.","family":"Shirley","sequence":"first","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Shamay","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Zahnow","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Diane","family":"Hayward","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111712074240900_B1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2019111712074240900_B2","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002.","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"issue":"9","key":"2019111712074240900_B3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"issue":"13","key":"2019111712074240900_B4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas.","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111712074240900_B5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumour virus: 50 years of Burkitt's lymphoma.","volume":"6","author":"Thorley-Lawson","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"2019111712074240900_B6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/10428190802311417","article-title":"Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas.","volume":"49","author":"Cohen","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"14","key":"2019111712074240900_B7","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0959-8049(02)00241-1","article-title":"Tumour viruses\u2013could they be an Achilles' heel of cancer?","volume":"38","author":"Farrell","year":"2002","journal-title":"Eur J Cancer"},{"issue":"4","key":"2019111712074240900_B8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.","volume":"78","author":"Feng","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"2019111712074240900_B9","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2019111712074240900_B10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.1864","article-title":"Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.","volume":"14","author":"Fu","year":"2008","journal-title":"Nat Med"},{"issue":"10","key":"2019111712074240900_B11","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2004-09-3569","article-title":"The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production.","volume":"105","author":"Klass","year":"2005","journal-title":"Blood"},{"issue":"22","key":"2019111712074240900_B12","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2019111712074240900_B13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1158\/1078-0432.CCR-06-2295","article-title":"Virus-associated tumor imaging by induction of viral gene expression.","volume":"13","author":"Fu","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2019111712074240900_B14","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111712074240900_B15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.cdd.4402279","article-title":"Fold up or perish: unfolded protein response and chemotherapy.","volume":"15","author":"Strasser","year":"2008","journal-title":"Cell Death Differ"},{"issue":"6","key":"2019111712074240900_B16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/10428190902895780","article-title":"Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells.","volume":"50","author":"Dong","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2019111712074240900_B17","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1128\/JVI.61.12.3672-3679.1987","article-title":"Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.","volume":"61","author":"Countryman","year":"1987","journal-title":"J Virol"},{"issue":"3","key":"2019111712074240900_B18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.64.3.1143-1155.1990","article-title":"The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.","volume":"64","author":"Lieberman","year":"1990","journal-title":"J Virol"},{"issue":"21","key":"2019111712074240900_B19","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1128\/JVI.78.21.11962-11971.2004","article-title":"Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1.","volume":"78","author":"Lin","year":"2004","journal-title":"J Virol"},{"key":"2019111712074240900_B20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(06)97004-3","article-title":"Lytic cycle switches of oncogenic human gammaherpesviruses.","volume":"97","author":"Miller","year":"2007","journal-title":"Adv Cancer Res"},{"issue":"14","key":"2019111712074240900_B21","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1128\/JVI.02666-09","article-title":"Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication.","volume":"84","author":"Rennekamp","year":"2010","journal-title":"J Virol"},{"issue":"9","key":"2019111712074240900_B22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/sj.onc.1206204","article-title":"C\/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer.","volume":"22","author":"Hattori","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"2019111712074240900_B23","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00282.2006","article-title":"Treatment of cultured myotubes with the proteasome inhibitor beta-lactone increases the expression of the transcription factor C\/EBPbeta.","volume":"292","author":"Wei","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"2019111712074240900_B24","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/JVI.77.2.1481-1500.2003","article-title":"CCAAT\/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.","volume":"77","author":"Wu","year":"2003","journal-title":"J Virol"},{"issue":"24","key":"2019111712074240900_B25","doi-asserted-by":"crossref","first-page":"13267","DOI":"10.1128\/JVI.77.24.13267-13274.2003","article-title":"Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"issue":"9","key":"2019111712074240900_B26","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JVI.78.9.4847-4865.2004","article-title":"CCAAT\/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.","volume":"78","author":"Wu","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"2019111712074240900_B27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1128\/JVI.80.3.1098-1109.2006","article-title":"Contribution of C\/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.","volume":"80","author":"Huang","year":"2006","journal-title":"J Virol"},{"issue":"18","key":"2019111712074240900_B28","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2009-01-201111","article-title":"C\/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.","volume":"114","author":"Pal","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2019111712074240900_B29","doi-asserted-by":"crossref","first-page":"e9516","DOI":"10.1371\/journal.pone.0009516","article-title":"C\/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models.","volume":"5","author":"Meir","year":"2010","journal-title":"PLoS ONE"},{"key":"2019111712074240900_B30","first-page":"141","article-title":"Role of Epstein-Barr virus in Burkitt's lymphoma.","volume":"258","author":"Takada","year":"2001","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"2019111712074240900_B31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CAD.0b013e3280101006","article-title":"Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virus-infected gastric carcinoma cell line.","volume":"18","author":"Ji Jung","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"3","key":"2019111712074240900_B32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0092-8674(91)90531-3","article-title":"A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.","volume":"67","author":"Descombes","year":"1991","journal-title":"Cell"},{"issue":"33","key":"2019111712074240900_B33","doi-asserted-by":"crossref","first-page":"22443","DOI":"10.1074\/jbc.M801046200","article-title":"Differential control of the CCAAT\/enhancer-binding protein beta (C\/EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress.","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"issue":"24","key":"2019111712074240900_B34","doi-asserted-by":"crossref","first-page":"11510","DOI":"10.1158\/0008-5472.CAN-05-2394","article-title":"Bor-tezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.","volume":"65","author":"Nawrocki","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"2019111712074240900_B35","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1074\/jbc.M109.014092","article-title":"Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells.","volume":"285","author":"Armstrong","year":"2010","journal-title":"J Biol Chem"},{"issue":"18","key":"2019111712074240900_B36","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1128\/JVI.02241-06","article-title":"Bor-tezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.","volume":"81","author":"Zou","year":"2007","journal-title":"J Virol"},{"key":"2019111712074240900_B37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1743-422X-6-231","article-title":"EBNA3C interacts with Gadd34 and counteracts the unfolded protein response.","volume":"6","author":"Garrido","year":"2009","journal-title":"Virol J"},{"issue":"3","key":"2019111712074240900_B38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/JVI.79.3.1379-1388.2005","article-title":"Herpes simplex virus 1 infection activates the endoplasmic reticulum resident kinase PERK and mediates eIF-2alpha dephosphorylation by the gamma(1) 34.5 protein.","volume":"79","author":"Cheng","year":"2005","journal-title":"J Virol"},{"issue":"21","key":"2019111712074240900_B39","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1128\/JVI.01330-10","article-title":"Human cytomegalovirus induces the endoplasmic reticulum chaperone BiP through increased transcription and activation of translation by using the BiP internal ribosome entry site.","volume":"84","author":"Buchkovich","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"2019111712074240900_B40","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2007-07-100032","article-title":"The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.","volume":"111","author":"Lee","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111712074240900_B41","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1158\/0008-5472.CAN-09-0277","article-title":"Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngeal carcinoma.","volume":"69","author":"Hsiao","year":"2009","journal-title":"Cancer Res"},{"issue":"24","key":"2019111712074240900_B42","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1128\/JVI.01055-07","article-title":"Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.","volume":"81","author":"Sun","year":"2007","journal-title":"J Virol"},{"issue":"14","key":"2019111712074240900_B43","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1128\/JVI.00154-07","article-title":"X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D.","volume":"81","author":"Bhende","year":"2007","journal-title":"J Virol"},{"issue":"pt 3","key":"2019111712074240900_B44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1099\/vir.0.017277-0","article-title":"Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency.","volume":"91","author":"McDonald","year":"2010","journal-title":"J Gen Virol"},{"issue":"23","key":"2019111712074240900_B45","doi-asserted-by":"crossref","first-page":"12362","DOI":"10.1128\/JVI.00712-10","article-title":"The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C\/EBP proteins.","volume":"84","author":"Bristol","year":"2010","journal-title":"J Virol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/23\/6297\/1339647\/zh802311006297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/23\/6297\/1339647\/zh802311006297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T21:45:00Z","timestamp":1637444700000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/23\/6297\/22281\/Bortezomib-induction-of-CEBP%CE%B2-mediates-EpsteinBarr"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,9]]},"references-count":45,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2011,6,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-332379","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,9]]}}}